EarningsQ2 2026 Earnings Report

Supernus Pharmaceuticals (S49) Q2 2026 Earnings Report

1 Followers

CH:S49 Q2 2026 EPS Results

Actual EPSCHF0.44

Consensus EPSCHF0.35

Beat/MissBeat by +CHF0.09

One Year Ago EPSCHF0.75

Actual RevenueCHF181.86M

Expected RevenueCHF170.45M

Beat/MissBeat by +CHF11.41M

YoY Revenue Growth+32.40%

QuarterQ2 2026

Date08/03/2026

TimeBefore Open

Conference CallMonday, August 3, 2026

CH:S49 Upcoming Earnings

Supernus Pharmaceuticals's next earnings date is estimated for November 10, 2026, based on past reporting schedules.

CH:S49 Q2 2026 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 10, 2026	2026 (Q3)	0.51 / -	0.834	―
Aug 03, 2026	2026 (Q2)	0.35 / 0.44	0.754	-42.07% (-0.32)
May 05, 2026	2026 (Q1)	0.25 / 0.50	0.364	37.44% (+0.14)
Feb 24, 2026	2025 (Q4)	0.28 / 0.70	0.619	13.40% (+0.08)
Nov 04, 2025	2025 (Q3)	0.49 / 0.83	0.97	-13.96% (-0.14)
Aug 05, 2025	2025 (Q2)	0.39 / 0.75	0.64	17.77% (+0.11)
May 06, 2025	2025 (Q1)	0.31 / 0.36	0.382	-4.78% (-0.02)
Feb 25, 2025	2024 (Q4)	0.43 / 0.62	0.733	-15.52% (-0.11)
Nov 04, 2024	2024 (Q3)	0.37 / 0.97	-0.241	502.76% (+1.21)
Aug 06, 2024	2024 (Q2)	0.32 / 0.64	-0.017	3955.00% (+0.66)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed